6
Y.ꢀR. WANG ET AL.
at δ 5.82 (1H, dt, J = 15.5, 7.5 Hz, H-23), 6.18 (1H, d, J = 15.5 Hz, H-24), and 4.85, 4.86
H
(
2H, br s, H-26) in 2. is suggested that the side-chain of the aglycone of 3 was an addition
2
5
product of 2, and 3 was obtained by adding a molecule CH OH on the double bond (Δ )
3
of 2. e HMBC correlation from the methoxyl at δ 3.09 to C-25 at δ 75.1 suggested the
methoxy group was linked to C-25. e presence of two anomeric protons of glycosyls at δ
H
C
H
4
.38 (1H, d, J = 7.5 Hz, H-1″) and 4.36 (1H, d, J = 8.0 Hz, H-1′), and two signals of anomeric
carbons at δ 100.9 (C-1″) and 100.2 (C-1′) supported the presence of two glycosyl moieties
C
in the molecule. Additionally, one set of carbon signals for ꢀ-arabinopyranose and one set of
1
3
carbon signals for ꢁ-quinovopyranose were observed in the C NMR spectrum of 3 [15].
Acid hydrolysis of 3 furnished arabinose and quinovose. e HMBC correlation from δ
H
.38 (H-1″) and δ 76.6 (C-12) indicated the quinovopyranose was linked at C-12 (Figure
C
), and the HMBC correlation from δ 4.36 (H-1′) and δ 81.2 (C-3) was not observed, but
H
C
the arabinopyranose was linked to C-3 on the basis of the chemical shif at δ 81.2 (C-3).
C
Ultimately, the structure of 3 was deduced as (20S, 23E)-dammarane-25-methoxy-3α,12β-
2
0-trihydroxy-23-en-12-O-β-ꢁ-quinovopyranosyl-3-O-α-ꢀ-arabinopyranoside, and 3 was
named cyclocarioside Q.
Compounds 1–3 exhibited no cytotoxicity against five human cancer cell lines, TNF-α
inhibitory activity observed in LPS-induced murine peritoneal macrophages (RAW264.7)
and hepatoprotective effect via inhibiting the proliferation of HepG2.
3
. Experimental
3
.1. General experimental procedures
Melting points were recorded on an XT5B micromelting point apparatus (Tianjin Optical
Instrument Factory, Tianjin, China). Optical rotations were measured on PE Model 343
polarimeter (PerkinElmer Enterprise Management Co., Ltd, Shanghai, China). UV spec-
trum was measured with a JASCO V-650 spectrophotometer (JASCO Corporation, Tokyo,
Japan). IR spectrum was recorded on a Nicolet 5700 spectrometer using an FT-IR micro-
scope transmission method (ermo Electron Corporation, Madison, WI, U.S.A). NMR
spectra were obtained on an Varian INOVA-500 MHz spectrometer (Varian, Inc., Palo Alto,
CA, U.S.A) in acetone-d . Mass spectrum was measured on a Mass Agilent 1100 Series
6
LC-MSD-Trap-SL spectrometer (ESI-MS) and 6520 ESI-TOF spectrometer (HR-ESI-MS)
(Agilent Technologies Ltd., Santa Clara, CA, U.S.A). High-performance liquid chromatog-
raphy (HPLC) was carried out on a Shimadzu instrument: pump LC-6AD, UV detector:
SPD-20A (Shimadzu Corporation, Tokyo, Japan), and a semipreparative reversed-phase col-
umn: Grace, Allsphere ODS-25 μm, 250×10 mm (Grace Corporation,Columbia, Maryland,
U.S.A.). Column chromatography (CC) was performed on silica gel (Qingdao Marine
Chemical Factory, Qingdao, China), RP-18 (45–75 μm, YMC CO., Ltd, Kyoto, Japan), and
Sephadex LH-20 (GE Healthcare Corporation, Uppsala, Sweden). in layer chromatogra-
phy (TLC) was performed on silica gel plates (GF254, Yantai Chemical Industry Research
Insititute, Yantai, China) and RP-18F254 plates (Merck Corporation, New Jersey, U.S.A).
e analytical and chromatographic grade solvents were purchased from Beijing Chemical
Corporation (Beijing, China). Arabinose (A0515) was purchased from J&K CHEMICA Co.,
Ltd. (Beijing, China), and quinovose (D9761-100 mg) was purchased from Sigma-Aldrich